1. Home
  2. ACNB vs YDES Comparison

ACNB vs YDES Comparison

Compare ACNB & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ACNB Corporation

ACNB

ACNB Corporation

HOLD

Current Price

$60.84

Market Cap

595.5M

Sector

Finance

ML Signal

HOLD

YDES

YD Bio Limited Ordinary Shares

HOLD

Current Price

$2.47

Market Cap

543.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACNB
YDES
Founded
1857
2013
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
595.5M
543.0M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
ACNB
YDES
Price
$60.84
$2.47
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$58.00
N/A
AVG Volume (30 Days)
71.9K
344.1K
Earning Date
04-23-2026
05-12-2026
Dividend Yield
3.00%
N/A
EPS Growth
N/A
N/A
EPS
1.32
N/A
Revenue
$191,821,000.00
N/A
Revenue This Year
$13.18
N/A
Revenue Next Year
$1.91
N/A
P/E Ratio
$46.85
N/A
Revenue Growth
45.10
N/A
52 Week Low
$41.03
$1.70
52 Week High
$62.07
$25.00

Technical Indicators

Market Signals
Indicator
ACNB
YDES
Relative Strength Index (RSI) 59.12 46.64
Support Level $48.10 $2.14
Resistance Level $61.73 $3.05
Average True Range (ATR) 1.38 0.41
MACD -0.04 0.11
Stochastic Oscillator 63.39 57.04

Price Performance

Historical Comparison
ACNB
YDES

About ACNB ACNB Corporation

ACNB Corp is the financial holding company. Through its wholly-owned subsidiaries, it provides a full range of retail and commercial financial services in Pennsylvania and Maryland through its network of community banking offices. It also provides property, casualty, health, life and disability insurance serving personal and commercial clients through offices in Westminster, Maryland, and Gettysburg, Pennsylvania and is licensed to do business. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage; and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: